By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has granted early termination of the review period for Danaher's proposed $6.8 billion acquisition of Beckman Coulter, according to a notice posted on the agency's website today.

The firms had announced the deal in early February, and at the time said they expected to complete the transaction in the first half of 2011.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.